IP Library Granted Patent US 6,919,191
Granted Patent B2
US 6,919,191 · App. 10/283,247 · Granted Jul 19, 2005

Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,919,191
App. No.
10/283,247
Granted
Jul 19, 2005
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the kinase peptides, and methods of identifying modulators of the kinase peptides.

Claims (24)

1. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule consists of a nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence that encodes a polypeptide having an amino acid sequence comprising SEQ ID NO:2;

(b) SEQ ID NO:1;

(c) SEQ ID NO:3;

(d) nucleotides 2258-67382 of SEQ ID NO:3; and

(e) a nucleotide sequence that is completely complementaiy to the nucleotide sequence of (a), (b), (c), or (d).

2. An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:

(a) a transcript or cDNA sequence that encodes a polypeptide having an amino acid sequence comprising SEQ ID NO:2;

(b) SEQ ID NO:1; and

(c) a nucleotide sequence that is completely complementary to the nucleotide sequence of (a) or (b).

3. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule consists of SEQ ID NO:1 or the complete complement thereof.

4. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule comprises SEQ ID NO:1 or the complete complement thereof.

5. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule consists of SEQ ID NO:3 or the complete complement thereof.

6. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule consists of nueleotides 2258-67382 of SEQ ID NO:3, or the complete complement thereof.

7. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule consists of a nucleotide sequence that encodes a polypeptide comprising SEQ ID NO:2, or the complete complement of said nucleotide sequence.

8. An isolated transcript or cDNA nucleic acid molecule comprising a nucleotide sequence that encodes a polypeptide comprising SEQ ID NO:2, or the complete complement of said nucleotide sequence.

9. A nucleic acid construct comprising the nucleic acid molecule of claim 1 or 2 fused to a heterologous nucleotide sequence.

10. The nucleic acid construct of claim 9 , wherein the heterologous nucleotide sequence encodes a heterologous amino acid sequence.

11. A vector comprising the nucleic acid molecule of claim 1 or 2 .

12. An isolated host cell containing the vector of claim 11 .

13. A process for producing a polypeptide, the process comprising culturing the host cell of claim 12 under conditions sufficient for the production of said polypeptide, and recovering said polypeptide.

14. The vector of claim 11 , wherein said vector is selected from the group consisting of a plasmid, a virus, and a bacteriophage.

15. The vector of claim 11 , wherein said nucleic acid molecule is inserted into said vector in proper orientation and correct reading frame such that a polypeptide comprising SEQ ID NO:2 is expressed by a cell transformed with said vector.

16. The vector of claim 15 , wherein said isolated nucleic acid molecule is operatively linked to a promoter sequence.

Assignments (3)
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →